Summary

Losartan Market – Scope of Report
TMR’s report on the global losartan market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global losartan market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global losartan market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the losartan market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global losartan market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global losartan market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global losartan market.

The report delves into the competitive landscape of the global losartan market. Key players operating in the global losartan market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global losartan market profiled in this report.

Key Questions Answered in Global losartan Market Report
• What is the sales/revenue generated by losartan across all regions during the forecast period?
• What are the opportunities in the global losartan market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Losartan Market – Research Objectives and Research Approach
The comprehensive report on the global losartan market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global losartan market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global losartan market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Losartan Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Losartan Market Analysis and Forecast, 2020-2034
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product /Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Losartan Market Analysis and Forecast, by Dosage Form
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Dosage Form, 2020-2034
        6.3.1. Tablet
        6.3.2. Powder
        6.3.3. Suspension
    6.4. Market Attractiveness Analysis, by Dosage Form
7. Global Losartan Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Application, 2020-2034
        7.3.1. Hypertension
        7.3.2. Stroke
        7.3.3. Diabetic Nephropathy
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Losartan Market Analysis and Forecast, by Distribution Channel
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Distribution Channel, 2020-2034
        8.3.1. Contract Manufacturing
        8.3.2. In-house Manufacturing
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Losartan Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2020-2034
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Losartan Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Dosage Form, 2020-2034
        10.3.1. Tablet
        10.3.2. Powder
        10.3.3. Suspension
    10.4. Market Value Forecast, by Application, 2020-2034
        10.4.1. Hypertension
        10.4.2. Stroke
        10.4.3. Diabetic Nephropathy
        10.4.4. Others
    10.5. Market Value Forecast, by Distribution Channel, 2020-2034
        10.5.1. Contract Manufacturing
        10.5.2. In-house Manufacturing
        10.5.3. Others
    10.6. Market Value Forecast, by Country, 2020-2034
        10.6.1. U.S.
        10.6.2. Canada
    10.7. Market Attractiveness Analysis
        10.7.1. By Dosage Form
        10.7.2. By Application
        10.7.3. By Distribution Channel
        10.7.4. By Country
11. Europe Losartan Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Dosage Form, 2020-2034
        11.3.1. Tablet
        11.3.2. Powder
        11.3.3. Suspension
    11.4. Market Value Forecast, by Application, 2020-2034
        11.4.1. Hypertension
        11.4.2. Stroke
        11.4.3. Diabetic Nephropathy
        11.4.4. Others
    11.5. Market Value Forecast, by Distribution Channel, 2020-2034
        11.5.1. Contract Manufacturing
        11.5.2. In-house Manufacturing
        11.5.3. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Italy
        11.6.5. Spain
        11.6.6. Rest of Europe
    11.7. Market Attractiveness Analysis
        11.7.1. By Dosage Form
        11.7.2. By Application
        11.7.3. By Distribution Channel
        11.7.4. By Country/Sub-region
12. Asia Pacific Losartan Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Dosage Form, 2020-2034
        12.3.1. Tablet
        12.3.2. Powder
        12.3.3. Suspension
    12.4. Market Value Forecast, by Application, 2020-2034
        12.4.1. Hypertension
        12.4.2. Stroke
        12.4.3. Diabetic Nephropathy
        12.4.4. Others
    12.5. Market Value Forecast, by Distribution Channel, 2020-2034
        12.5.1. Contract Manufacturing
        12.5.2. In-house Manufacturing
        12.5.3. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
        12.7.1. By Dosage Form
        12.7.2. By Application
        12.7.3. By Distribution Channel
        12.7.4. By Country/Sub-region
13. Latin America Losartan Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Dosage Form, 2020-2034
        13.3.1. Tablet
        13.3.2. Powder
        13.3.3. Suspension
    13.4. Market Value Forecast, by Application, 2020-2034
        13.4.1. Hypertension
        13.4.2. Stroke
        13.4.3. Diabetic Nephropathy
        13.4.4. Others
    13.5. Market Value Forecast, by Distribution Channel, 2020-2034
        13.5.1. Contract Manufacturing
        13.5.2. In-house Manufacturing
        13.5.3. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
        13.7.1. By Dosage Form
        13.7.2. By Application
        13.7.3. By Distribution Channel
        13.7.4. By Country/Sub-region
14. Middle East & Africa Losartan Market Analysis and Forecast
    14.1. Introduction
    14.2. Key Findings
    14.3. Market Value Forecast, by Dosage Form, 2020-2034
        14.3.1. Tablet
        14.3.2. Powder
        14.3.3. Suspension
    14.4. Market Value Forecast, by Application, 2020-2034
        14.4.1. Hypertension
        14.4.2. Stroke
        14.4.3. Diabetic Nephropathy
        14.4.4. Others
    14.5. Market Value Forecast, by Distribution Channel, 2020-2034
        14.5.1. Contract Manufacturing
        14.5.2. In-house Manufacturing
        14.5.3. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
        14.6.1. GCC Countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
        14.7.1. By Dosage Form
        14.7.2. By Application
        14.7.3. By Distribution Channel
        14.7.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2023)
    15.3. Company Profiles
        15.3.1. Merck & Co., Inc.
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Pfizer Inc.
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Teva Pharmaceutical Industries Ltd.
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Dr. Reddy’s Laboratories Ltd.
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Sun Pharmaceutical Industries Limited
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Aurobindo Pharma Ltd
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. Torrent Pharmaceuticals Limited
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. Lupin Limited
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview